Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Onco-Innovations Ltd. ( (TSE:ONCO) ) just unveiled an announcement.
Onco-Innovations Limited’s subsidiary, Inka Health, has been chosen by OneMedNet Corporation to lead an AI-driven oncology project utilizing real-world data for external control arms. This initiative aims to reduce the time and cost of bringing cancer therapies to market by leveraging existing patient data, potentially accelerating treatment access and reducing reliance on traditional clinical trials. The project highlights the growing importance of real-world data in cancer therapeutics and positions Onco-Innovations as a leader in innovative evidence generation strategies, particularly in areas with high unmet needs like colorectal cancer.
More about Onco-Innovations Ltd.
Onco-Innovations Limited is a company operating in the healthcare industry, focusing on oncology and cancer therapeutics. Its subsidiary, Inka Health Corp., specializes in data analytics and artificial intelligence solutions aimed at improving cancer treatment development and market entry.
Average Trading Volume: 91,770
Technical Sentiment Signal: Strong Sell
Find detailed analytics on ONCO stock on TipRanks’ Stock Analysis page.